Family Medicine · Gardena, CA
NPI
1841619095
Since 2014
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
15420 Crenshaw Blvd
Gardena, CA, 90249
Phone (310) 324-5599
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
2,429 services
Medicare patients, 2024
358
Average age 75
Drug cost, 2024
$2.5M
13,838 prescriptions
Company payments, 2025
$1,906
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hoangvy Le was code 99214 (office e&m - established), 825 times for 289 patients. In total Hoangvy Le billed 2,429 services in 27 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 825 | 289 | $81.70 | $67K |
| 36415 Venipuncture Blood Collection | Office | 751 | 310 | $8.65 | $6,496 |
| 99213 Office E&M - Established | Office | 649 | 226 | $56.65 | $37K |
| 90653 Vaccine Product | Office | 29 | 29 | $81.82 | $2,373 |
| 96372 Injection Administration | Office | 17 | 15 | $10.52 | $179 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 13 | 13 | $132.54 | $1,723 |
By year: 2022 $121K for 1,780 services; 2023 $131K for 2,343 services; 2024 $118K for 2,429 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 751 | 310 | $8.65 | $6,496 |
Medicare prescription drug claims, 2024
In 2024, the drug Hoangvy Le prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,244 prescriptions and refills. In total Hoangvy Le wrote 13,838 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,244 | 3,358 | 360 | $8,623 |
| Amlodipine Besylate Generic | 569 | 1,481 | 160 | $1,828 |
| Fluticasone Propionate Generic | 420 | 617 | 155 | $4,351 |
| Diclofenac Sodium Generic | 369 | 451 | 168 | $157K |
| Rosuvastatin Calcium Generic | 361 | 970 | 97 | $4,566 |
| Gabapentin Generic | 289 | 579 | 99 | $2,608 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 266 | 653 | 66 | $3,620 |
| Losartan Potassium Generic | 261 | 733 | 82 | $2,360 |
| Farxiga Dapagliflozin Propanediol | 257 | 591 | 70 | $324K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 250 | 583 | 62 | $302K |
| Alendronate Sodium Generic | 245 | 612 | 63 | $1,310 |
| Metoprolol Succinate Generic | 242 | 608 | 63 | $3,059 |
| Azelastine Hcl Generic | 220 | 374 | 68 | $4,484 |
| Celecoxib Generic | 202 | 225 | 96 | $1,764 |
| Benazepril Hcl Generic | 200 | 557 | 62 | $1,576 |
Brand drugs: 1,880 claims; generic drugs: 11,917 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hoangvy Le $1,906 ($1,906 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $507.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 23 | $507 |
| Aimmune Therapeutics, Inc. | 12 | $257 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $198 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $185 |
| Agios Pharmaceuticals, Inc. AGIO | 6 | $181 |
| Gilead Sciences, Inc. GILD | 5 | $98.42 |
| Lilly USA, LLC LLY | 4 | $95.04 |
| Kowa Pharmaceuticals America, Inc. | 4 | $71.57 |
| Pfizer Inc. PFE | 3 | $65.9 |
| Novo Nordisk Inc NVO | 2 | $44.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.